Abstract
A variety of diseases may lead to liver cirrhosis, with alcohol abuse, viral hepatitis, and steatohepatitis being the most common entities in the Western world. Liver cirrhosis is one of the main risk factors for developing hepatocellular carcinoma (HCC). The radiologist’s role in the workup of patients with liver cirrhosis is of utmost importance, as imaging findings oftentimes serve as the basis for selecting the most appropriate treatment strategy, e.g., surgical resection, locoregional therapy, or transplantation.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Ringe KI, Husarik DB, Sirlin CB, Merkle EM (2010) Gadoxetate disodium-enhanced MRI of the liver: part 1, protocol optimization and lesion appearance in the noncirrhotic liver. AJR Am J Roentgenol 195:13–28.
Cruite I, Schroeder M, Merkle EM, Sirlin CB (2010) Gadoxetate-enhanced MR imaging of the liver: Part 2: Protocol optimization and lesion appearance in the cirrhotic liver. AJR Am J Roentgenol 195:29–41.
Husarik DB, Gupta RT, Ringe KI et al (2011) Contrast enhanced liver MRI in patients with primary sclerosing cholangitis: inverse appearance of focal confluent fibrosis on delayed phase MR images with hepatocyte specific versus extracellular gadolinium based contrast agents. Acad Radiol 18:1549–1554.
Anon (1995) Terminology of nodular hepatocellular lesions. Hepatology 22:983–993.
Chou CT, Chen YL, Su WW et al (2010) Characterization of cirrhotic nodules with gadoxetic acid-enhanced magnetic resonance imaging: the efficacy of hepatocyte-phase imaging. J Magn Reson Imaging 32: 895–902.
Rhee H, Kim MJ, Park MS, Kim KA (2012) Differentiation of early hepatocellular carcinoma from benign hepatocellular nodules on gadoxetic acid-enhanced MRI. Br J Radiol 85: e837–e844.
Bartolozzi C, Battaglia V, Bargellini I et al (2013) Contrast-enhanced magnetic resonance imaging of 102 nodules in cirrhosis: correlation with histological findings on explanted livers. Abdom Imaging 38:290–296.
Zech CJ, Reiser MF, Herrmann KA (2009) Imaging of hepatocellular carcinoma by computed tomography and magnetic resonance imaging: state of the art. Dig Dis 27:114–124.
Bruix J, Sherman M (2011) Management of hepatocellular carcinoma: an update. Hepatology 53:1020–1022.
Forner A, Llovet JM, Bruix J (2012) Hepatocellular carcinoma. Lancet 379:1245–1255.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2014 Springer-Verlag Italia
About this chapter
Cite this chapter
Heye, T.J., Merkle, E.M. (2014). Diffuse Liver Disease: Cirrhosis and Vascular Diseases. In: Hodler, J., von Schulthess, G.K., Kubik-Huch, R.A., Zollikofer, C.L. (eds) Diseases of the Abdomen and Pelvis 2014–2017. Springer, Milano. https://doi.org/10.1007/978-88-470-5659-6_10
Download citation
DOI: https://doi.org/10.1007/978-88-470-5659-6_10
Publisher Name: Springer, Milano
Print ISBN: 978-88-470-5658-9
Online ISBN: 978-88-470-5659-6
eBook Packages: MedicineMedicine (R0)